Table 1.
Association between different patient and cancer-specific variables with CRP elevation prior to penile cancer surgery
| Variable | CRP ≤ 15 mg/l | CRP > 15 mg/l | p-value |
|---|---|---|---|
| Age, median [years] (IQR)1 |
64.8 (58-71) |
70.3 (62-77) |
0.07 |
| BMI, median [kg/m2] (IQR)1 |
26.6 (24.1-29.4) |
26.1 (21.9-28.3) |
0.19 |
| Stage |
|
|
0.012 |
| pTis |
11 (18.3%) |
1 (5.3%) |
|
| pTa |
3 (5.0%) |
1 (5.3%) |
|
| pT1 |
24 (40.0%) |
3 (15.8%) |
|
| pT2 |
17 (28.3%) |
6 (31.6%) |
|
| pT3 |
4 (6.7%) |
5 (26.3%) |
|
| pT4 |
1 (1.7%) |
3 (15.8%) |
|
| Nodal metastasis1 |
|
|
0.007 |
| N0 |
41 (83.7%) |
7 (46.7%) |
|
| N+ |
8 (16.3%) |
8 (53.3%) |
|
| Grade |
|
|
0.53 |
| G1 |
11 (22.9%) |
2 (11.1%) |
|
| G2 |
25 (52.1%) |
10 (55.6%) |
|
| G3/4 | 12 (25.0%) | 6 (33.3%) |
1 at time of penile cancer surgery. Abbreviations: CRP = C-reactive protein, N = nodal status.